Kristijan Henry Kahler
- Demographic, clinical and health care resource utilisation characterisation of patients prescribed omalizumab: A retrospective, real world data studyBy Michael Baldwin, Gerardo Machnicki, Lingling Li, Zhijun Wei, Tzy-Chyi Yu and Kristijan Henry KahlerMichael Baldwin1Health Economics and Outcomes Research, Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United KingdomGerardo Machnicki2Medical and Drug Regulatory Affairs, Novartis Argentina S.A., Buenos Aires, ArgentinaLingling Li3Ningbo Pain/OS, Beijing Novartis Pharma Co. Ltd, Jiaxing, Zhejiang Province, ChinaZhijun Wei3Ningbo Pain/OS, Beijing Novartis Pharma Co. Ltd, Jiaxing, Zhejiang Province, ChinaTzy-Chyi Yu4Health Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ,Kristijan Henry Kahler4Health Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ,
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.